Welwyn Garden City, UK – 20th November 2012 – Cresset, innovative provider of chemistry software and services, announces that Es-is Technologies Ltd has chosen to license torchV10 for use in enzyme engineering. torchV10 is Cresset’s desktop molecular design software, widely used by medicinal chemists for drug design.
“The decision of Es-is, an enzyme design company, to work with torchV10 demonstrates the flexibility of our products and the value and insight that they bring to researchers working outside our core base of small molecule drug design,” says Dr David Bardsley, Cresset’s Sales Director.
Dr Amit Kessel, Head of Computational R&D at Es-is says, “We are excited about using torchV10 for the rational engineering of enzymes. We design novel enzyme-based syntheses for active ingredients in pharmaceutical drugs and our computational design process relies on a rational approach. torchV10 will provide us with valuable information about enzyme-substrate electrostatic interactions, helping us to streamline our processes.”
Dr Bardsley adds, “Cresset’s software works at the meeting point of chemistry and biology, giving chemists a way of understanding their molecules in terms of biological activity. Cresset’s technology and services are providing companies with the right information, wherever they sit in the drug design workflow.”
*******
Cresset Group: Dr Robert Scoffin +44 1707 356120 Email: rob@cresset-group.com
Es-is Technologies Ltd: Dr Amit Kessel +972 54 4530210 Email: amit@es-is.com
___________________________________________